|Articles|January 1, 2003

Resources

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Weekly review: CDC's updated website, roflumilast 0.3%, and more

ByJoshua Fitch, Senior Editor

November 23rd 2025

George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label

ByGeorge M. Rodgers, III, MD, PhD

November 22nd 2025

Transforming teen obesity care: How integrated specialty pharmacy models expand GLP-1 access

ByThao-Ly Phan, MD, MPH,Linhda Nguyen, PA-C

November 21st 2025

Daniele De Luca discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development | Image credit: Author provided

Daniele De Luca, MD, discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development

ByDaniele De Luca, MD, PhD,Joshua Fitch, Senior Editor

November 21st 2025

Practical reminders, considerations for anaphylaxis care, with Alice Hoyt, MD, FAAAI

ByAlice Hoyt, MD, FAAAAI

November 20th 2025

Latest CME

Multimedia

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Multimedia

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Multimedia

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Resources

Newsletter

Related Content

Weekly review: CDC's updated website, roflumilast 0.3%, and more

George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label

Transforming teen obesity care: How integrated specialty pharmacy models expand GLP-1 access

Daniele De Luca, MD, discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development

Practical reminders, considerations for anaphylaxis care, with Alice Hoyt, MD, FAAAI

Latest CME

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Weekly review: CDC's updated website, roflumilast 0.3%, and more

George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label